🔥🐔 BizChicken 🐔🔥
Companies Similar to Zentalis Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Enliven Therapeutics, Inc.
small molecule kinase inhibitors
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.
About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About | Vision/Values
Symbol: ELVN
Recent Price: $22.39
Industry: Biotechnology
CEO: Mr. Samuel S. Kintz M.B.A.
Sector: Healthcare
Employees: 52
Address: 6200 Lookout Road, Boulder, CO 80301
Phone: 720 647 8519
Leadership
- Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
- Joe Lyssikatos, Co-founder, Chief Scientific Officer
- Anish Patel, Co-founder and Chief Operating Officer
- Helen Collins, Chief Medical Officer
- Ben Hohl, Chief Financial Officer and Head of Corporate Development
- Galya Blachman, Chief Legal Officer and Head of Business Development
- Rich A. Heyman, Chairman of the Board of Directors
- Rishi Gupta, Member of the Board of Directors
- Andy Phillips, Member of the Board of Directors
- Mika Kakefuda Derynck, Member of the Board of Directors
- Jake Bauer, Member of the Board of Directors
- Rahul Ballal, Member of the Board of Directors
- Lori Kunkel, Member of the Board of Directors
- Brian Druker, Scientific Advisor
- Kevin Koch, Scientific Advisor
Last updated: 2024-12-31
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Zentalis Pharmaceuticals, Inc.
ZN-c3, ZN-c5
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.
About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: ZNTL
Recent Price: $2.92
Industry: Biotechnology
CEO: Dr. Kimberly Lynn Blackwell M.D.
Sector: Healthcare
Employees: 124
Address: 1359 Broadway, New York, NY 10018
Phone: 212 433 3791
Last updated: 2024-12-31
Aclaris Therapeutics, Inc.
Zunsemetinib
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.
Contact | Careers | About | About | Directors | Leadership | About | Careers | About | About | Jobs
Symbol: ACRS
Recent Price: $2.48
Industry: Medical - Diagnostics & Research
CEO: Dr. Neal S. Walker D.O., M.D.
Sector: Healthcare
Employees: 86
Address: 640 Lee Road, Wayne, PA 19087
Phone: 484 324 7933
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
MEI Pharma, Inc.
Zandelisib
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.
About | About | About | Contact | Contact | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Careers | Careers | Careers | About | About | About | About | About | Jobs | About
Symbol: MEIP
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Justin J. File
Sector: Healthcare
Employees: 28
Address: 11455 El Camino Real, San Diego, CA 92130
Phone: 858 369 7100
Last updated: 2024-12-31
Marinus Pharmaceuticals, Inc.
ZTALMY
Marinus Pharmaceuticals, Inc. focuses on the development and commercialization of therapies for rare genetic epilepsies and other seizure disorders, offering products like ZTALMY for cyclin-dependent kinase-like 5 deficiency disorder and developing ganaxolone for genetic epilepsy disorders.
About | Leadership | Directors | About | About | About | Leadership | About | About | Contact | Careers | About | About | About | About
Symbol: MRNS
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. Scott N. Braunstein M.D.
Sector: Healthcare
Employees: 165
Address: 5 Radnor Corporate Center, Radnor, PA 19087
Phone: 484 801 4670
Leadership
- Scott Braunstein, M.D., Chairman of the Board & Chief Executive Officer
- Steven E. Pfanstiel, Chief Financial Officer and Chief Operating Officer
- Joseph Hulihan, M.D., Chief Medical Officer
- Christy Shafer, Chief Commercial Officer
- Martha Manning, Esq., Senior Vice President, General Counsel and Secretary
- Alex Aimetti, Ph.D., Chief Scientific Officer
- Kimberly McCormick, PharmD, Chief Regulatory and Quality Assurance Officer
- Sonya Weigle, SVP, Human Resources, IR & Corporate Affairs
- David Czekai, Chief Chemistry, Manufacturing and Controls Officer
- Tim M. Mayleben, Lead Independent Board Director
- Chuck Austin, Director
- Elan Ezickson, Director
- Seth H.Z. Fischer, Director
- Marvin H. Johnson, Jr., Director
- Sara Nochur, Ph.D., Director
- Christine Silverstein, Director
- Sarah Noonberg, M.D., Ph.D., Director
- ,
- Josias, Clinical Trial Manager
- Powell, Associate Director, Clinical Development Operations
- Chasity, Regional Account Manager – Houston
- Sandy, Regional Account Manager – Cincinnati
- Amy, Regional Account Manager – Southeast
- Tuula, Executive Director, Product Development
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Nuvalent, Inc.
NVL-520 and NVL-655
Nuvalent, Inc. is a clinical stage biopharmaceutical company that develops therapies for patients with cancer, focusing on brain-penetrant inhibitors for ROS1 and ALK.
Symbol: NUVL
Recent Price: $77.87
Industry: Biotechnology
CEO: Dr. James R. Porter Ph.D.
Sector: Healthcare
Employees: 115
Address: One Broadway, Cambridge, MA 02142
Phone: 857 357 7000
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Y-mAbs Therapeutics, Inc.
DANYELZA
Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.
Symbol: YMAB
Recent Price: $7.76
Industry: Biotechnology
CEO: Mr. Michael Rossi
Sector: Healthcare
Employees: 100
Address: 230 Park Avenue, New York, NY 10169
Phone: 646 885 8505
Leadership
- Michael Rossi, President and Chief Executive Officer
- Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
- Torben Lund-Hansen, SVP, Chief Technical Officer
- Peter Pfreundschuh, Chief Financial Officer
- Vignesh Rajah, SVP, Chief Medical Officer
- Joris Wilms, SVP, Chief Operating Officer
- Sue Smith, SVP, Chief Commercial Officer
- Norman LaFrance, Chief Development Officer
- Johan Wedell-Wedellsborg, Chairman
- Ashutosh Tyagi, M.D.,
- James I. Healy, Chairman
- David N. Gill,
- Laura J. Hamill,
- Mary Tagliaferri, M.D.,
Last updated: 2024-12-31
Catalent, Inc.
Drug and health product solutions
Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products globally. It operates through segments like Biologics, Softgel and Oral Technologies, among others.
About | About | Leadership | About | About | DEI | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | DEI | Careers | Benefits | Careers | About | About | About | About
Symbol: CTLT
Recent Price: $63.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Alessandro Maselli
Sector: Healthcare
Employees: 17000
Address: 14 Schoolhouse Road, Somerset, NJ 08873
Phone: 732 537 6200
Last updated: 2024-12-31
Zoetis Inc.
Animal Health Medicines, Vaccines, and Diagnostic Products
Zoetis Inc. discovers, develops, and commercializes a wide range of animal health products including medicines, vaccines, and diagnostics, serving both livestock and companion animals globally.
Careers | Our Story | Awards | Sustainability | Foundation | Locations | About | ESG | About | Our Story | Directors | Contact | Careers | Careers | Careers | Our Story | Awards | Sustainability | Foundation | Locations | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | News | News | News | News | News | Careers | Careers | Careers | Careers | DEI | Careers | Our Story | Directors | Careers | Careers | Careers | Careers | Contact | Careers | Careers | About | About | About | About
Symbol: ZTS
Recent Price: $162.24
Industry: Drug Manufacturers - Specialty & Generic
CEO: Ms. Kristin C. Peck
Sector: Healthcare
Employees: 14100
Address: 10 Sylvan Way, Parsippany, NJ 07054
Phone: 973 822 7000
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31